Early Career Investigator in Gastroesophageal Cancer Translational Research Gastrointestinal Oncology Service - Department of Medicine

The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized compassionate expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent diagnose and treat it. MSK is dedicated to training the next generation of scientists and clinicians who go on to pursueour missionat MSK and around the globe.

The Gastrointestinal Oncology Service in the Division of Solid Tumor Oncology Department of Medicine is seeking an investigator with expertise in translational and clinical research focused on gastroesophageal cancers. This investigator will be appointed as the Debbies Dream Foundation Gastric Cancer Investigator and will play a pivotal role in advancing patient care research and education in esophageal and gastric cancers.

This is an exciting opportunity for a dedicated researcher to join one of the worlds leading cancer centers. Under the mentorship of Dr. Yelena Janjigian Chief of the Gastrointestinal Oncology Service the investigator will have up to one year (with the possibility of extension) of protected research time to focus on biomarker development laboratory research and translational studies in gastroesophageal cancer.

Key Responsibilities:

• Participate in clinical trials and translational research to advance gastroesophageal cancer treatments.
• Conduct innovative research leveraging clinical data biospecimens and translational research methodologies.
• Collaborate with multiple laboratories to analyze molecular genetic and experimental data to drive discoveries.
• Assist in the development of grant proposals for major funding agencies including NIH DoD and private foundations.
• Draft and publish highimpact manuscripts abstracts and research findings.

Why Join Us

• CuttingEdge Research Be part of a highly productive research program leading 25 active clinical trials including key contributions to the FDA approvals of nivolumab pembrolizumab/trastuzumab and trastuzumab deruxtecan for gastroesophageal cancers.
• Mentorship & Collaboration Work directly with Dr. Janjigian and a worldclass team of translational and clinical researchers dedicated to revolutionizing cancer care.
• Meaningful Impact Your research will directly influence patient outcomes shaping the future of gastroesophageal cancer treatment.

Qualifications:

• MD MD/PhD or PhD in oncology translational medicine molecular biology or a related field.
• Expertise in translational research molecular/genetic concepts and data analysis.
• Experience in biomarker development immunooncology or targeted therapies is highly desirable.
• Excellent communication collaboration and leadership skills.

Location: New York New York

Salary Range: $80000 $125000

Interested candidates should submit:

• Curriculum Vitae (CV)
• Cover Letter outlining research interests and career goals
• Contact information for three references

Submit applications to:
Patrick Evans Senior Project Manager

MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race color gender gender identity or expression sexual orientation national origin age religion creed disability veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.

Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures providing documents in an alternate format using a sign language interpreter or using specialized equipment.